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Abstract: In this study, a gas-chromatography mass spectrometry (GC-MS) metabolomics study was
applied to examine urine metabolite profiles of different classes of neonates under different nutrition
regimens. The study population included 35 neonates, exclusively either breastfed or formula milk
fed, in a seven-day timeframe. Urine samples were collected from intrauterine growth restriction
(IUGR), large for gestational age (LGA), and appropriate gestational age (AGA) neonates. At birth,
IUGR and LGA neonates showed similarities in their urine metabolite profiles that differed fromAGA.
When neonates started milk feeding, their metabolite excretion profile was strongly characterized by
the different diet regimens. After three days of formula milk nutrition, urine had higher levels of
glucose, galactose, glycine and myo-inositol, while up-regulated aconitic acid, aminomalonic acid
and adipic acid were found in breast milk fed neonates. At seven days, neonates fed with formula
milk shared higher levels of pseudouridine with IUGR and LGA at birth. Breastfed neonates shared
up-regulated pyroglutamic acid, citric acid, and homoserine, with AGA at birth. The role of most
important metabolites is herein discussed.
Keywords: breastfeeding; formula milk; metabonomics; IUGR; LGA; AGA; myo-inositol;
glycine; pseudouridine
1. Introduction
Nutrition plays a key role in the life of every human being and can affect the quality of life in
several ways. Nowadays, it is common knowledge that obesity and the risk to develop metabolic
syndrome are correlated with either excessive or insufficient fetal nutrition [1,2]. It is also important
how the nutrition in neonates could affect their future life quality or could prevent the risk of chronic
pathologies. The “thrifty phenotype hypothesis”, by Hales et al. [3] proposes an association among
low birth weight and increased risk in adulthood of developing diseases, helping to understand how
to treat these patients and to reach new qualitative and valid standards in the field of infant nutrition.
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Newborns are classified as adequate for the gestational age (AGA), when the weight is between the
10th and 90th percentile, while neonates with a weight over the 90th percentile are defined as large for
gestational age (LGA), and those below the 10th percentile are small for the gestational age. Neonates
with an intrauterine growth restriction (IUGR) have at birth a weight or a body mass index lower than
normal for the number of gestational weeks [4]. Newborns belonging to the IUGR and LGA groups
show a reduced carbohydrate tolerance with hypoglycemia [2]; this condition can lead in adulthood
to a higher risk of metabolic diseases, such as type 2 diabetes and obesity. Besides intra-uterine
quality of nutrition, diet in the first weeks of life can determine the future life of newborns. A valid
alternative to the recommended breastfeeding is the use of formula milk, and to assess the effects in
neonate metabolism is of primary importance in the field of nutrition. A noninvasive way of targeting
this issue is the study of the metabolite urine excretion of formula milk (FM) and breastfed (BM)
individuals. In this regard, a gas-chromatography mass spectrometry (GC-MS) based metabolomics
has proven to be a good analytical tool candidate. Metabolomics is a new field of research, based on
the quantitative analysis, over time, of the metabolic changes of a living system to pathological and
physiological stimuli and genetic modifications [5]. This approach allowed evaluation of changes in
neonate metabolism due to anthropometric parameters (IUGR and LGA) and nutrition [6–13]. The aim
of the present study, based on a GC-MS metabolomics approach, was to ascertain whether and to what
extent different diet regimens affect the urine metabolite profiles of IUGR, AGA and LGA neonates fed
exclusively with either human breast milk (BM) or with formula milk (FM).
2. Results
A total of 113 urine samples of AGA, IUGR and LGA neonates at T1 (at birth), T2 (three days) and
T3 (seven days) were analysed by GC-MS. Representative chromatograms at T1 are shown in Figure 1.
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From the analysis of the chromatograms, we observed 53 urine metabolites, such as short chain
hydroxylated acids, long chain fatty acids, free amino acids, and mono- and disaccharides. Nineteen
compounds were not identified and thereafter named U1–U19 (Table 1).
Table 1. Gas-chromatography mass spectrometry (GC-MS) characteristics of urine metabolites.
Compound Rt (min) EI-MS, m/z (amu) (%Relative Abundance) Trivial Name Abbr
Alanine 16.72 116 (100), 73 (50), 147 (30) alanine ALA
Glycine (2 TMS) 17.14 102 (100), 73 (50), 147 (45) glycine (2 TMS) GLY2
Oxalic acid 17.48 147 (100), 73 (80), 133 (50) oxalic acid OXA
3-Hydroxybutanoic acid 17.86 147 (100), 73 (50), 117 (45) 3-hydroxybutyric acid 3HBA
Benzoic acid 19.36 179 (100), 105 (64), 135 (55) benzoic acid BA
Glycine (3 TMS) 20.23 174 (100), 73 (50), 248 (47) glycine (3 TMS) GLY3
Butanedioic acid 20.37 147 (100), 73 (50), 247 (45) succinic acid BUA
2,3-Dihydroxypropanoic acid 20.54 171 (100), 100 (50), 292 (45) glyceric acid GLYA
2,3-Dihydroxybutanoic acid 20.72 73 (100), 292 (50), 147 (45) 2,3-dihydroxybutyric acid DHB
Serine 20.99 204 (100), 73 (70), 218 (65) serine SER
Threonine 21.33 73 (100), 218 (94), 291 (50) threonine THR
Unknown 1 21.70 103 (100), 73 (90), 219 (60) U1
3,4-Dihydroxybutanoic acid 21.97 73 (100), 233 (60), 147 (50) 2-deoxytetronic acid DOT A
Homoserine 22.21 218 (100), 73 (50), 128 (50) homoserine HOMO
Aminomalonic acid 22.49 147 (100), 73 (95), 218 (90) aminomalonic acid AMIN A
Unknown 2 22.57 158 (100), 68 (50), 147 (45) U2
Unknown 3 22.92 73 (100), 217 (90), 147 (80) U3
Hexanedioic acid 22.99 73 (100), 111 (68), 147 (50) adipic acid HA
Aspartic acid 23.12 232 (100), 73 (90), 100 (40) aspartic acid ASP A
5-Oxo-1-proline 23.19 156 (100), 73 (50), 147(40) pyroglutamic acid PYR A
2,3,4-Trihydroxybutanoic acid 23.39 73 (100), 292 (90), 147 (50) threonic acid THR A
2-Hydroxypentanedioic acid 23.80 129 (100), 147 (90), 247 (80) 2-hydroxyglutaric acid HGLU A
Unknown 4 24.34 73 (100), 231 (90), 147 (43) U4
Phenylalanine 24.46 333 (100), 73 (80), 218 (40) phenylalanine PHEN
Unknown 5 24.50 73 (100), 200 (80), 267 (70) U5
Unknown 6 24.79 73 (100), 103 (60), 217 (50) U6
Ribose 24.94 73 (100), 205 (50), 147 (40) ribose RIB
Unknown 7 25.08 73 (100), 147 (90), 247 (70) U7
Xylitol 25.44 73 (100), 217 (90), 307 (55) xylitol XYL
Fucose 25.5 117 (100), 73 (90), 217 (76) fucose FUC
Unknown 8 25.67 73 (100), 117 (90), 160 (30) U8
1-Propene-1,2,3-tricarboxylic acid 25.83 73 (100), 147 (90), 229 (50) aconitic acid ACO A
Unknown 9 25.93 73 (100), 292 (70), 357 (40) U9
1,2,3-Propanetricarboxylic acid 26.58 273 (100), 147 (60), 73 (60) citric acid CIT A
Unknown 10 26.93 73 (100), 217 (92), 147 (70) U10
Galactose 27.29 73 (100), 319 (90), 205 (60) galactose GAL
Glucose 27.52 73 (100), 319 (72), 205 (54) glucose GLU
Unknown 11 27.75 333 (100), 73 (58), 160 (43) U11
Unknown 12 28.04 373 (100), 73 (90), 358 (70) U12
Hexadecanoic acid 28.95 313 (100), 117 (90), 73 (90) palmitic acid HEX A
Unknown 13 29.16 73 (100), 103 (43), 244 (28) U13
Myo-inositol 29.29 305 (100), 217 (90), 73 (53) myoinositol MYO
Octadecanoic acid 30.75 341 (100), 205 (98), 117 (76) stearic acid OCT A
Pseudouridine 31.43 217 (100), 73 (50), 357 (40) pseudouridine PURID
Unknonwn 14 31.87 73 (100), 217 (50), 246 (49) U14
Unknonwn 15 32.01 217 (100), 73 (55), 147 (40) U15
Unknonwn 16 32.44 285 (100), 73 (55), 186 (40) U16
2,3-Dihydroxy hexadecanoic acid 33.52 371 (100), 73 (40), 147 (40) 2,3-dihydroxyhexadecanoic acid DHH A
Glucopyranoside 33.82 217 (100), 73 (90), 147 (60) glucopyranoside GPYR
Unknonwn 17 34.21 204 (100), 73 (90), 361 (80) U17
Unknonwn 18 34.33 204 (100), 73 (90), 361 (80) U18
Unknonwn 19 34.71 204 (100), 73 (70), 361 (62) U19
2,3-Dihydroxy octadecanoic acid 34.95 73 (100), 191 (90), 361 (70) 2,3-dihydroxy octadecanoic acid DHO A
TMS = trimethylsilyl derivative.
To investigate similarities and differences among samples on the basis of their metabolite profiles,
a multivariate approach was applied. For this purpose, we created a matrix composed of 94 samples
and 53 variables (metabolites). First, to study sample distribution and to detect outliers or common
features, we ran a principal component analysis (PCA) for T1, T2 and T3. Surprisingly, no sample
clusterization was observed on the basis of sex or neonate weight (data not shown). At T1, the
metabolite profiles of IUGR and LGA samples overlapped. For this reason, we decided to group IUGR
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and LGA samples in a single class and to compare it to AGA samples by a pair-wise orthogonal partial
least square discriminant analysis (OPLS-DA). This discriminant analysis demonstrated that, at birth,
urine of IUGR and LGA neonates have a different metabolite profile than AGA neonates (see score
plot in Figure 2; R2Y = 0.71, Q2Y = 0.36).
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Figure 2. Orthogonal partial least square discriminant analysis (OPLS-DA) of appropriate gestational
age (AGA) vs. intrauterine growth restriction (IUGR) + large for gestational age (LGA) neonates at
birth, R2Y = 0.71, Q2Y = 0.36. Score plot, triangles represent the AGA class, filled and e pty circles
LGA and IUGR, respectively. Separation of classes is axi ized through the predictive co ponent
(x-axis), intraclass variability is described through the orthogonal co ponent (y-axis).
From the analysis of the loading plot (data not shown) the most discriminating metabolites were:
glucopyranoside, citric acid, and pyroglutamic acid for AGA, whilst threonic acid, pseudouridine
and ribose for IUGR and LGA neonates. At T2 and T3, after feeding, IUGR and LGA cannot be
differentiated from AGA. Therefore, we performed an OPLS-DA considering the urine of AGA, IUGR
and LGA neonates at T2 and classifying them into two classes: breastfed and formula milk fed. A good
discrimination was found between the two groups of neonates (R2Y = 0.81; Q2Y = 0.69) as shown in
the score plot of Figure 3, with levels of glucose, galactose, and glycine higher in urine of neonates fed
with FM, while aconitic acid, aminomalonic acid and adipic acid discriminated the BM diet.
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Figure 3. OPLS-DA of breast milk (BM) vs. formula milk (FM) fed neonates at T2, R2Y = 0.81 and
Q2Y = 0.69. Score plot, triangles represent the AGA class, filled and empty circles LGA and IUGR,
respectively. Black and grey colours represent BM and FM feeding, respectively. Separation of classes
is maximized through the predictive component (x-axis), intraclass variability is described through the
orthogonal component (y-axis).
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For the two classes levels of these latter metabolites are reported in Figure 4. Other discriminant
metabolites were myo-inositol, pseudouridine, citric acid and homoserine for FM, ribose for BM (data
not shown).
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The good performance of this model indicated a strong influence of diet in the urine metabolite
profiles of neonates. A pair-wise OPLS-DA to the urine samples collected at T3 for BM vs. FM neonates
was performed. This discriminant analysis (R2Y = 0.88, Q2Y = 0.61) indicated that also t T3 the
diet strongly influenced urine metabolite profile. T e score plot (Figu 5) shows hat samples were
correct y separated into two groups a d that BM samples are more scattered than FM, highlighting in
the former a higher intra-class variability.
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represent the AGA class, filled and empty circles LGA and IUGR, respectively. Black and grey colours
represent BM and FM feeding, respectively.
Int. J. Mol. Sci. 2016, 17, 265 6 of 12
By the analysis of loadings, we selected the most discriminant metabolites reported as box plot in
Figure 6: pseudouridine, glycine and serine were up-regulated in the FM class, while 2-hydroxyglutaric
acid, pyroglutamic and citric acid were up-regulated in the BM class. Other discriminant metabolites
were threonine and myo-inositol for the FM class, while ribose, homoserine and oxalic acid for the BM
class (data not shown).
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3. Discussion
3.1. Discriminant Metabolites for the Different Feeding Regimes
In this study, urine samples of newborns fed exclusively with BM or exclusively with FM at
T2 and T3 were collected and analyzed. After the shift of nutrient supply from placenta to milk,
the metabolic profile of IUGR, AGA and LGA newborns was more affected by diet than by their
anthropometric parameters. At T2 and T3 breastfed babies showed different urine metabolite profiles
compar d to those FM fed. The discriminant metabolites reflect the metabolic interactions betw en
the neonates and their diet. Specifically, at T2 the up-regulated metabolites in FM fed neonates were
glucose, galact , glycine, p udouridine, citric acid, myo-inositol, and homoserine. The higher
levels of glucose and galactose measured in FM compared with breast milk together with the higher
intesti l permeability of FM fed neonates can explain t e high r xcretion of these sugars in FM fed
neonates [14]. At T2, urine of neonates fed BM s owed higher levels of aconitic acid, aminomalonic
acid and adipic acid when compared to FM. The higher levels of adipic acid, probably reflect an
elevated lipolysis and augmented catabolism of fatty acids in these neonates to compensate the low
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energy level of colostrum [15,16]. This hypothesis can be also valid for aconitic acid that is a Krebs
cycle compound. Aminomalonic acid is an amino dicarboxylic acid derived from cysteine and marker
of oxidative stress [17].
At T3, discriminant metabolites for FM fed were pseudouridine, glycine, serine, threonine,
and myo-inositol. Noteworthy, newborns fed with FM shared the same representative metabolites
(pseudouridine,myo-inositol and glycine) with IUGR and LGA neonates at birth, which raises questions
about the quality of FM, especially when compared with BM. The benefits of breastfeeding are a topic
of interest in medicine, involving different fields, from gynecology to pediatrics [18]. It is well known
that breastfeeding affects both mother and child positively [19,20]. BM neonates were higher in
pyroglutamic acid, a compound of the glutathione cycle, found up-regulated in AGA neonates at
birth. Friesen et al. [21] measured the plasma pyroglutamic acid levels in pregnant women and in
their newborns finding that pyroglutamic acid was 56% elevated in pregnant women, and with higher
levels in fetal plasma compared with maternal plasma [22]. Jackson A. et al. [23] reported that, when
compared with adults, neonates excrete five to ten times the amount of pyroglutamic acid.
3.2. Maternal Malnutrition and Consequences on Neonates’ Health
Several events may occur during intrauterine life, which could influence the future life of the
fetus. In the case of IUGR neonates, maternal malnutrition, smoking and placental vascular disease
are the main causes for not reaching full growth potential, with a lower body mass index and weight
for the number of gestational weeks [24,25]. On the other hand, macrosomia is characterized by an
increased body mass index and weight above the 90th percentile for gestational age. The main risk
factors are: maternal diabetes, obesity and nutrition/weight gain during pregnancy [26].
Both fetal hyponutrition (IUGR) and hypernutrition (LGA) at birth can favor the developing of
a low carbohydrate tolerance due to hypoglycemia. These findings can be strengthened by results
of our study, in fact, the analysis of the samples collected in the first day of life revealed similarities
between IUGR and LGA neonates when compared to AGA neonates, LGA and IUGR sharing the same
up-regulated metabolites: threonic acid, pseudouridine, ribose, and, to a lesser extent, myo-inositol,
and glycine. Lawson et al. [27] reported that erythronic acid and threonic acid urine excretion was
altered in adult individuals fed with synthetic diet rich of high carbohydrates.
In our statistical model, LGA and IUGR neonates at birth showed up-regulated threonic acid
suggesting an altered carbohydrates metabolism. Recently, D-ribose has been found to be present at an
abnormally high concentration in the urine of type 2 diabetics, suggesting a key role in metabolism
carbohydrates disorders [28]. Su et al. [28] demonstrated that mouse spatial cognitive impairment
is caused by ribose derived advanced glycation end products, partially proving a risk factor for
IUGR neonates’ cognitive dysfunction [29,30]. Higher levels of glycine and myo-inositol in IUGR and
LGA neonates were already observed in our recent works [31,32]. The occurrence of myo-inositol
in the urine is in accordance with the reduced carbohydrate tolerance due to the hypoglycemic and
hyperglycemic status of IUGR and LGA neonates during the fetal life, and it should be considered
as a marker of an altered glucose metabolism during fetal development [33]. Moreover, newborns
consume glycine to produce purines and heme, providing one third of the residues for the formation of
collagen and elastin [34], and is produced by the placenta in large amounts [23,26]. Gannon et al. [35]
have demonstrated that the ingestion of glycine induced an increase of glucagon levels. Furthermore,
when glycine is ingested with glucose, the insulin peak occurs later and is lower if compared to when
glucose is ingested alone [35].
Glycine plays also a key role in the synthesis of the glutathione (GSH), which is an intracellular
scavenger of free radicals and reactive oxygen species. Numerous diseases in premature neonates,
such as bronchopulmonary dysplasia, periventricular leukomalacia, intraventricular hemorrhage,
retinopathy of prematurity and necrotizing enterocolitis have been associated to oxidative stress,
decreased GSH, and free radical-mediated tissue injury [36–40]. In presence of diabetes or high
glucagon levels, the oxidation of glycine in hepatic cells increases and it may become a limiting
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factor in the synthesis of GSH [41]. Different studies showed that glycine availability is able to limit
erythrocyte GSH synthesis in burn patients [42] or in malnourished children [43]. Up-regulated urine
levels of glycine in both IUGR and LGA neonates after birth may reflect the altered metabolic status of
these infants, which appears to be predominantly catabolic, with a potential oxidative stress damage.
Pseudouridine is an atypical nucleoside found in human urine as an RNA metabolite, specifically the
degradation rate of rRNA was determined through the excretion of pseudouridine. Literature data
suggest that the excretion rate of pseudouridine in healthy people is a valid non-invasive indicator of
resting metabolic rate [44]. From the evidence that pseudouridine inhibits basal glucose consumption
in rat soleus muscle, Dzúrik et al. [45] concluded that pseudouridine inhibits glucose use in the calcium
modulation of the insulin regulatory cascade.
In the metabolic profile of AGA neonates, representative metabolites were glucopyranoside and
organic acids such as citric acid, and benzoic acid. It has been postulated that urinary low molecular
weight organic acid excretion in the neonate, which differs from the adult urinary pattern, suggests




This study was carried out on 113 urine samples from patients admitted to the Neonatal Intensive
Care Unit, Puericulture Institute and Neonatal Section, Azienda Ospedaliera Universitaria, University
of Cagliari (Cagliari, Italy) and to the Neonatal Intensive Unit and Neonatal Pathology of “S. Giovanni
Calibita” Hospital Fatebenefratelli (Rome, Italy). The study protocol was approved by the local ethical
committee and written informed consent was obtained from the parents before enrolment in the
study (CA-206-18/03/2013). According to the anthropometric classification, neonates were divided in
three groups: (1) AGA, n = 14 of which 6/8 males/females, mean gestational age 38.3 weeks, mean
birth-weight (BW) 3033 ˘ 287 g (percentiles = 49.2); (2) IUGR, n = 10, 5/5 m/f, mean gestational age of
37 weeks, mean BW 2313 ˘ 365 g (percentiles = 6.9); (3) LGA, n = 11, 5/6 m/f, mean gestational age of
38.6 weeks, mean BW of 3858 ˘ 313 g (percentiles = 94.3). Urine samples were matched for sex, age,
gestation and type of delivery, and were collected at different times: within 8 h of birth prior to the
administration of food (first urine output) (T1), at the third day of life (T2) and at the seventh day of
life (T3). The total number of samples collected was 31 for AGA (T1 = 14; T2 = 9; T3 = 8), 30 for IUGR
(T1 = 10; T2 = 8; T3 = 12) and 33 (T1 = 11; T2 = 14; T3 = 8) for LGA. From T2, data regarding the infants’
feeding regime were also collected, selecting only neonates fed exclusively with either FM or BM and
excluding infants with mixed feeding (n = 19). At T2, 15 neonates of the studied population were fed
with BM (7 AGA, 3 LGA, 5 IUGR) and 16 with FM (2 AGA, 11 LGA, 3 IUGR). At T3, 16 neonates were
fed with BM (6 AGA, 6 LGA, 4 IUGR) and 12 with FM (2 AGA, 2 LGA, 8 IUGR). All the newborns
survived. The clinical data of each patient was recorded in the hospital registers.
4.2. Chemicals
Chemicals, analytical standards and solvents were purchased from (Sigma Aldrich, Milano, Italy).
Derivatized 2,2,3,3-d4-succinic acid was used as internal standard. Methoxyamine hydrochloride,
N,O-bis(trimethylsilyl)trifluoroacetamide, trimethylchlorosilane (BSTFA + TMCS) were used for
derivatization purposes.
4.3. Urine Samples Collection and Preparation
Urine samples (2–3 mL) were collected using a non-invasive method with a ball of cotton, then
aspirated with a syringe and transferred to a sterile 15 mL Falcon tube. The tubes were then stored
at ´80 ˝C. GC-MS, analyses were carried out at the Department of Life and Environmental Sciences
laboratories in Cagliari. After thawing on ice, the urine samples were centrifuged for 10 min at
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13,200 rpm. One hundred and fifty µL of supernatant from each sample were transferred to Eppendorf
tubes containing 1 mg of urease, sonicated for 30 min at 37 ˝C and then centrifuged for 10 min at
13,200 rpm. The supernatant was separated and after drying derivatized with 50 µL of methoxyamine
in pyridine solution (10 mg/mL). After 17 h, 100 µL of BSTFA + TMCS were added and after 1 h
samples were resuspended with 600 µL of hexane. Trimethylsylilated 2,2,3,3-d4-succinic acid at 5 mg/L
was used as internal standard.
4.4. GC-MS Analysis
Analysis was conducted injecting one microliter of derivatized sample in a 6850 gas
chromatograph attached with a 5973 Network mass spectrometer (Agilent Technologies, Santa Clara,
CA, USA). GC separation was obtained with a 30 m ˆ 0.25 mm ID, silica chemically bonded capillary
column (J&W Scientific, Folsom, CA, USA). The temperature of the injector was 200 ˝C and the
gas flow rate was 1 mL/min. The column initial temperature was mantained at 50 ˝C for 10 min
and then increased to 300 ˝C at 10 ˝C/min and held at 300 ˝C for 10 min. The transfer line and
the ion source temperatures were at 280 and 180 ˝C, respectively. Ions produced at 70 eV were
recorded at 1.6 scan/s in the mass range m/z 50–550. GC-MS data analysis was conducted by
integrating each resolved chromatogram peak and normalizing the area for the corrected total area of
the chromatogram. Peaks were examined for their mass spectra and their identification was performed
using the NIST08 library after deconvolution with an automated mass spectral deconvolution and
identification system (AMDIS).
4.5. Multivariate Data Analysis
Amultivariate data analysis was performed using the SIMCA software (version 13.0, Umetrics,
Umea, Sweden). Untargeted principal components analysis (PCA) was applied to visualize tendency
of samples to cluster on the basis of similarities in their metabolite profile and to detect the presence
of outliers. The latter can be detected by different tests, as implemented in SIMCA software.
For sample classification and for the search of biomarkers that differentiate the predefined classes, the
Orthogonal Partial Least Square-Discriminant Analysis (OPLS-DA) was performed, this is a supervised
classification method that requires information about class membership of samples. In OPLS-DA,
class separation is maximized in the predictive component (x-axis) and its orthogonal component
(y-axis) express intra-class variability. The goodness of models was evaluated by the parameters: 3R2Y
(goodness of classification) and Q2Y (goodness of classification in cross-validation) [46].
5. Conclusions
In summary, our results show that at birth the urinary metabolome of AGA neonates differs
from that of IUGR and LGA neonates, and that, when the nutrition supply moves from intrauterine
to lactation or bottle feeding, the typology of milk (breast or formula) strongly characterize the
urine metabolite profiles of neonates overcoming anthropometric classification. This confirmed the
importance of quality of nutrition in the first days of life and also proves that this GC-MS based
metabolomics approach is very sensitive to diet regimens and therefore endorses it as a helpful efficient
tool in the research field of neonatal feeding. While published studies exist on milk metabolomics, this
study, to our knowledge, the first report in literature, focuses on the different metabolic impacts that
breast milk and formula milk display in infants of different categories (IUGR, AGA, LGA) in the first
week of life. These data and ongoing studies on this topic may be very important from a practical point
of view in selecting the formula milks that not only have physicochemical properties more similar to
breast milk, but also determine metabolic and nutritional impacts similar to breast milk. We want to
highlight the importance for neonates to consume breast milk when possible, and the need for the
development of formula milk to more closely emulate breast milk. Future perinatal studies should
also take into account an integration with maternal metabolic data.
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